BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17145811)

  • 21. Characterization of Intercalated Cell Markers KIT and
    Mannan R; Wang X; Bawa PS; Zhang Y; Skala SL; Chinnaiyan AK; Dagar A; Wang L; Zelenka-Wang SB; McMurry LM; Daniel N; Cao X; Sangoi AR; Gupta S; Vaishampayan UN; Hafez KS; Morgan TM; Spratt DE; Tretiakova MS; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Int J Surg Pathol; 2023 Sep; 31(6):1027-1040. PubMed ID: 36250542
    [No Abstract]   [Full Text] [Related]  

  • 22. C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma.
    Zimpfer A; Janke S; Hühns M; Schneider B; Kundt G; Zettl H; Kilic E; Maruschke M; Hakenberg OW; Erbersdobler A
    Pathol Res Pract; 2014 Aug; 210(8):521-5. PubMed ID: 24875296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.
    Huang W; Kanehira K; Drew S; Pier T
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of a new isoform of DLG2 in renal oncocytoma.
    Zubakov D; Stupar Z; Kovacs G
    BMC Cancer; 2006 Apr; 6():106. PubMed ID: 16640776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study.
    Rocca PC; Brunelli M; Gobbo S; Eccher A; Bragantini E; Mina MM; Ficarra V; Zattoni F; Zamò A; Pea M; Scarpa A; Chilosi M; Menestrina F; Bonetti F; Eble JN; Martignoni G
    Mod Pathol; 2007 Jul; 20(7):722-8. PubMed ID: 17483815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
    Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
    AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.
    Sari ZB; Açikalin MF; Arik D; Özen A; Can C; Çolak E
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):534-540. PubMed ID: 33605572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Patton KT; Tretiakova MS; Yao JL; Papavero V; Huo L; Adley BP; Wu G; Huang J; Pins MR; Teh BT; Yang XJ
    Am J Surg Pathol; 2004 Aug; 28(8):1045-50. PubMed ID: 15252311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
    Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into the biology of renal cell carcinoma.
    Li L; Kaelin WG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):667-86. PubMed ID: 21763962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
    Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
    Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.
    Rowsell C; Fleshner N; Marrano P; Squire J; Evans A
    J Clin Pathol; 2007 Apr; 60(4):426-8. PubMed ID: 17405978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma.
    Brunelli M; Segala D; Delahunt B; Parolini C; Bersani S; Cheng L; Eble JN; Chilosi M; Gobbo S; Martignoni G
    Anticancer Res; 2011 Oct; 31(10):3137-42. PubMed ID: 21965719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
    Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
    Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
    Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
    Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
    Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
    Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
    Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
    Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
    Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.